The China Over the Counter Drugs was worth USD 18.24 billion in 2016 and estimated to reach USD 24.78 billion by the end of 2021 with a growing potential of 6.32%. China OTC Pharmaceuticals market accounts for 33.4% of total Asia-Pacific OTC market